Acquisition of Faeth and Pipe Issuance - Summary of Estimated Fair Value of Consideration Transferred (Details) - Faeth Therapeutics $ in Thousands |
Feb. 17, 2026
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Total consideration transferred | $ 145,836 |
| Assumed Options | |
| Business Combination [Line Items] | |
| Total consideration transferred | 452 |
| Series B Preferred Stock | |
| Business Combination [Line Items] | |
| Total consideration transferred | $ 145,384 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|